Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):127-33. doi: 10.1016/j.ijrobp.2013.05.024.
To study the utility of preoperative breast MRI for partial breast irradiation (PBI) patient selection, using multivariable analysis of significant risk factors to create a classification rule.
Between 2002 and 2009, 712 women with newly diagnosed breast cancer underwent preoperative bilateral breast MRI at Mayo Clinic Florida. Of this cohort, 566 were retrospectively deemed eligible for PBI according to the National Surgical Adjuvant Breast and Bowel Project Protocol B-39 inclusion criteria using physical examination, mammogram, and/or ultrasound. Magnetic resonance images were then reviewed to determine their impact on patient eligibility. The patient and tumor characteristics were evaluated to determine risk factors for altered PBI eligibility after MRI and to create a classification rule.
Of the 566 patients initially eligible for PBI, 141 (25%) were found ineligible because of pathologically proven MRI findings. Magnetic resonance imaging detected additional ipsilateral breast cancer in 118 (21%). Of these, 62 (11%) had more extensive disease than originally noted before MRI, and 64 (11%) had multicentric disease. Contralateral breast cancer was detected in 28 (5%). Four characteristics were found to be significantly associated with PBI ineligibility after MRI on multivariable analysis: premenopausal status (P=.021), detection by palpation (P<.001), first-degree relative with a history of breast cancer (P=.033), and lobular histology (P=.002). Risk factors were assigned a score of 0-2. The risk of altered PBI eligibility from MRI based on number of risk factors was 0:18%; 1:22%; 2:42%; 3:65%.
Preoperative bilateral breast MRI altered the PBI recommendations for 25% of women. Women who may undergo PBI should be considered for breast MRI, especially those with lobular histology or with 2 or more of the following risk factors: premenopausal, detection by palpation, and first-degree relative with a history of breast cancer.
通过多变量分析显著风险因素,为部分乳房照射(PBI)患者选择创建分类规则,研究术前乳房 MRI 的实用性。
2002 年至 2009 年期间,712 名新诊断为乳腺癌的女性在佛罗里达州梅奥诊所接受了双侧术前乳房 MRI。在这一组中,根据国家外科辅助乳房和肠道项目协议 B-39 的纳入标准,566 例患者回顾性地被认为符合 PBI 标准,该标准使用体格检查、乳房 X 线照片和/或超声检查。然后审查磁共振图像以确定其对患者资格的影响。评估患者和肿瘤特征,以确定 MRI 后改变 PBI 资格的危险因素,并创建分类规则。
最初符合 PBI 标准的 566 名患者中,141 名(25%)因病理证实的 MRI 结果而被认为不符合条件。磁共振成像检测到 118 例(21%)同侧乳腺癌。其中,62 例(11%)MRI 前发现的疾病比原来更广泛,64 例(11%)为多中心疾病。28 例(5%)检测到对侧乳腺癌。多变量分析发现 4 个特征与 MRI 后 PBI 不合格显著相关:绝经前状态(P=.021)、触诊发现(P<.001)、一级亲属有乳腺癌病史(P=.033)和小叶组织学(P=.002)。危险因素的评分范围为 0-2。基于危险因素的数量,MRI 改变 PBI 资格的风险为 0:18%;1:22%;2:42%;3:65%。
术前双侧乳房 MRI 改变了 25%的妇女的 PBI 建议。可能接受 PBI 的妇女应考虑进行乳房 MRI,特别是那些具有小叶组织学或具有以下 2 个或更多危险因素的妇女:绝经前、触诊发现和一级亲属有乳腺癌病史。